Vitro, S.A.B. de C.V. VITOF
OTC PK
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 7.88% | -24.11% | -43.94% | -55.80% | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.88% | -24.11% | -43.94% | -55.80% | -- |
| Cost of Revenue | 24.49% | -29.06% | -50.13% | -60.08% | -- |
| Gross Profit | -3.81% | -18.81% | -35.91% | -49.93% | -- |
| SG&A Expenses | 16.26% | 4.99% | -5.53% | -15.70% | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -15.89% | -108.11% | -14,098.04% | -812.04% | -- |
| Total Operating Expenses | 19.27% | -13.55% | -32.83% | -43.33% | -- |
| Operating Income | -106.17% | -142.77% | -262.98% | -2,550.39% | -- |
| Income Before Tax | 22.68% | 617.90% | 195.04% | 207.19% | -- |
| Income Tax Expenses | -175.26% | -144.35% | 255.19% | 199.17% | -- |
| Earnings from Continuing Operations | 73.22% | 550.76% | 190.29% | 208.50% | -- |
| Earnings from Discontinued Operations | 90.06% | 169.75% | 782.54% | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 79.71% | 3,229.08% | 252.90% | 233.86% | -- |
| EBIT | -106.17% | -142.77% | -262.98% | -2,550.39% | -- |
| EBITDA | -98.43% | -325.22% | -1,021.29% | -239.38% | -- |
| EPS Basic | 21.20% | 4,753.09% | 290.67% | 273.65% | -- |
| Normalized Basic EPS | -59.03% | 941.82% | 200.87% | 192.72% | -- |
| EPS Diluted | 19.64% | 4,714.81% | 289.27% | 273.65% | -- |
| Normalized Diluted EPS | -59.03% | 941.82% | 200.87% | 192.72% | -- |
| Average Basic Shares Outstanding | 11.99% | -6.90% | -10.62% | -20.91% | -- |
| Average Diluted Shares Outstanding | 11.99% | -6.90% | -10.62% | -20.91% | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |